AFM Dissipation Topography of Soliton Superstructures in Adsorbed Overlayers

In the atomic force microscope, the nanoscale force topography of even complex surface superstructures is extracted by the changing vibration frequency of a scanning tip. An alternative dissipation topography with similar or even better contrast has been demonstrated recently by mapping the (x,y)-dependent tip damping but the detailed damping mechanism is still unknown. Here we identify two different tip dissipation mechanisms: local mechanical softness and hysteresis. Motivated by recent data, we describe both of them in a onedimensional model of Moire' superstructures of incommensurate overlayers. Local softness at "soliton" defects yields a dissipation contrast that can be much larger than the corresponding density or corrugation contrast. At realistically low vibration frequencies, however, a much stronger and more effective dissipation is caused by the tip-induced nonlinear jumping of the soliton, naturally developing bistability and hysteresis. Signatures of this mechanism are proposed for experimental identification.Comment: 5 pages, 5 figures, Phys Rev B 81, 045417 (2010

Caractérisation de composés hybrides organique-inorganique à base de cuivre rencontrés en peinture (étude de leur formation et transformation)

Cette thèse, financée par la Fondation des Sciences du Patrimoine, Patrima, a pour but la compréhension du mécanisme chimique responsable du brunissement de certains pigments verts à base de cuivre, sous forme de complexes organométalliques, utilisés en peinture de l'Antiquité à la Renaissance. Il s'agit du vert de gris et du résinate de cuivre . La variation chromatique de ces pigments engendre une perte de lisibilité de l'œuvre et pose un important problème de conservation. La détermination des réactions impliquées dans l'altération est fondamentale pour définir une méthodologie d'intervention. Afin de clarifier le mécanisme responsable du changement de couleur il est nécessaire d'étudier d'une part la géométrie du centre métallique et d'autre part la nature des liaisons cuivre-ligand. Dans ce but une stratégie multianalytique a été développée. Elle est basée sur la reconstitution des composés utilisés par les artistes et de ceux qui peuvent se former dans les couches picturales, et sur leur caractérisation, avant et après un vieillissement accéléré (thermique oupar exposition à la lumière). La synthèse des ces systèmes modèles a permis d'évaluer l'influence de plusieurs paramètres (solvant, pH, température et temps de réaction) sur la structure des complexes. Les produits de départ et les composés de dégradation ont été analysés par différentes techniques. L'étude des morphologies et la répartition chimique du cuivre au sein des systèmes est réalisée par MEB -EDS. La structure moléculaire a été caractérisée par IRTF diffraction des rayons X, spectroscopie d'absorption des rayons X et par résonance paramagnétique électronique. La caractérisation des produits de dégradation présents dans la phase organique est effectuée par chromatographie en phase gazeuse couplée à la spectrométrie de masse. En parallèle l'étude de leurs propriétés optiques a été réalisée par spectroscopie UV-visible. Les données collectées sont comparées à celles obtenues, par les mêmes méthodes analytiques, sur des échantillons de couches picturales prélevés sur des œuvres peintes plus ou moins altérées. Ce travail comparatif a permis à la fois de mieux comprendre les mécanismes de formation et de transformation au cours du vieillissement de ces systèmes hybrides organique-inorganique, d'évaluer quels paramètres ont plus d'influence sur l'altération et de valider ou d'invalider certaines hypothèses proposées concernant les changements des propriétés optiques observées.This thesis, funded by Patrima, Foundation for Cultural Heritage Sciences, aims to understand the chemical mechanisms responsible for the darkening of some green copper organometallic pigments (Verdigris and copper resinate) widely used in paintings from Antiquity to the Renaissance. The color variation of these pigments involves a loss of legibility of the artwork and is a major conservation issue. The determination of the reactions involved in the alteration is fundamental to define an intervention methodology. In order to clarify the discoloration process it is necessary to get information on the geometry of the copper cluster and the nature of the copper-ligand bonds. With this aim, a multi-analytical methodology has been developed, based on the reconstitution of ancient pigment and of the compounds that can be formed in the paint layer. These model systems have been characterized before and after an accelerated ageing (by heat or light). Their synthesis has permitted to evaluate the influence of several parameters (solvent, pH, temperature and reaction time) on the resulting structure. The original materials and their degradation products have been analyzed by different techniques. The study of the morphology and chemical distribution of copper in the system was performed by SEM-EDS. The molecular structure was characterized by FTIR, XRD spectroscopy, X-ray absorption and EPR (Electronic Paramagnetic Resonance). The characterization of organic degradation products has been carried out by gas chromatography coupled to mass spectrometry. At the same time a study of optical properties has been performed by UV-visible spectroscopy. The data collected are compared to those obtained, by the same analytical methods, on samples of paint layers taken from ancient paintings. This comparative work has permitted to better understand the mechanisms of formation and transformation of these organic-inorganic systems, to assess which parameters influence the alteration, and to validate or invalidate some preliminary hypothesis about the chromatic changes.CERGY PONTOISE-Bib. electronique (951279901) / SudocSudocFranceF

Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series

BAY 81-8973 is an unmodified, full-length third generation recombinant factor VIII (rFVIII) which offers a more favorable pharmacokinetic (PK) profile, compared to its predecessor sucrose-formulated rFVIII (rFVIII-FS). We here report on a retrospective case series of nine patients affected by hemophilia A (HA), with variable disease severity, bleeding phenotype and comorbidities, to underline our clinical practice on prophylaxis with a recently introduced standard hall-life recombinant Factor VIII. The current case series highlights how the current clinical management of hemophilia is able to personalize treatment in several specific conditions like concomitant illnesses with thrombotic risk and allergic reactions

Improving assessment and management of pain in hemophilia. An Italian Delphi consensus statement

: Comprehensive evidence-based guidelines and well-validated assessment scales for pain in people with hemophilia (PwH) are needed. Here, we report 28 statements covering five topics on pain assessment and management in pediatric and adult PwH that were developed by 60 Italian hemophilia specialists during a Delphi consensus process. Overall, a clear consensus was achieved for 19 of the 28 statements. Consensus was reached on all statements on the topic of pain assessment and quality of life (QoL), including the need for regular pain assessment on a quantitative scale, the importance of distinguishing between different pain types, and the need to evaluate the impact of pain on patient QoL. The other four topics concerned acute and chronic pain management in adults and in children. Consensus was reached on statements regarding non-pharmacologic treatment and the use of first-line paracetamol (acetaminophen). There was a lack of consensus regarding the use of non-steroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, or opioids

Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein

Parkinson's disease (PD) presents the selective loss of A9 dopaminergic (DA) neurons of Substantia Nigra pars compacta (SNpc) and the presence of intracellular aggregates called Lewy bodies. alpha-synuclein (alpha-syn) species truncated at the carboxy-terminal (C-terminal) accumulate in pathological inclusions and promote alpha-syn aggregation and toxicity. Haemoglobin (Hb) is the major oxygen carrier protein in erythrocytes. In addition, Hb is expressed in A9 DA neurons where it influences mitochondrial activity. Hb overexpression increases cells' vulnerability in a neurochemical model of PD in vitro and forms cytoplasmic and nucleolar aggregates upon short-term overexpression in mouse SNpc. In this study, alpha and beta-globin chains were co-expressed in DA cells of SNpc in vivo upon stereotaxic injections of an Adeno-Associated Virus isotype 9 (AAV9) and in DA iMN9D cells in vitro. Long-term Hb over-expression in SNpc induced the loss of about 50% of DA neurons, mild motor impairments, and deficits in recognition and spatial working memory. Hb triggered the formation of endogenous alpha-syn C-terminal truncated species. Similar alpha-syn fragments were found in vitro in DA iMN9D cells over-expressing alpha and beta- globins when treated with pre-formed alpha-syn fibrils. Our study positions Hb as a relevant player in PD pathogenesis for its ability to trigger DA cells' loss in vivo and the formation of C-terminal alpha-syn fragments

Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study

IntroductionCurrent treatment for haemophilia A involves factor VIII replacement or non-replacement (emicizumab) therapies, neither of which permanently normalise factor VIII levels. Gene therapy using adeno-associated viral (AAV) vectors is an emerging long-term treatment strategy for people with severe haemophilia A (PwSHA) that is likely to be available for clinical use in the near future. AimThis article proposes practical guidelines for the assessment, treatment, and follow-up of potential PwSHA candidates for AAV-based gene therapy. MethodUsing the Delphi method, a working group of Italian stakeholders with expertise in and knowledge of the care of adults with haemophilia A analysed literature for AAV-based gene therapy and drafted a list of statements that were circulated to a panel of Italian peers. During two rounds of voting, panel members voted on their agreement with each statement to reach a consensus. ResultsThe Delphi process yielded 40 statements regarding haemophilia A gene therapy, across five topics: (1) organisational model; (2) multidisciplinary team; (3) patient engagement; (4) laboratory surveillance; and (5) patient follow-up and gene therapy outcomes. The consensus was reached for all 40 statements, with the second round of voting needed for five statements. ConclusionUse of the hub-and-spoke organisational model and multidisciplinary teams are expected to optimise patient selection for gene therapy, as well as the management of dosing and patient follow-up, patient engagement, laboratory surveillance, and patient expectations regarding outcomes. This approach should allow the benefits of AAV-based gene therapy for haemophilia A to be maximised

SINEUPs: a novel toolbox for RNA therapeutics

RNA molecules have emerged as a new class of promising therapeutics to expand the range of druggable targets in the genome. In addition to 'canonical' protein-coding mRNAs, the emerging richness of sense and antisense long non-coding RNAs (lncRNAs) provides a new reservoir of molecular tools for RNA-based drugs. LncRNAs are composed of modular structural domains with specific activities involving the recruitment of protein cofactors or directly interacting with nucleic acids. A single therapeutic RNA transcript can then be assembled combining domains with defined secondary structures and functions, and antisense sequences specific for the RNA/DNA target of interest. As the first representative molecules of this new pharmacology, we have identified SINEUPs, a new functional class of natural antisense lncRNAs that increase the translation of partially overlapping mRNAs. Their activity is based on the combination of two domains: an embedded mouse inverted SINEB2 element that enhances mRNA translation (effector domain) and an overlapping antisense region that provides specificity for the target sense transcript (binding domain). By genetic engineering, synthetic SINEUPs can potentially target any mRNA of interest increasing translation and therefore the endogenous level of the encoded protein. In this review, we describe the state-of-the-art knowledge of SINEUPs and discuss recent publications showing their potential application in diseases where a physiological increase of endogenous protein expression can be therapeutic

Phenotypic antimicrobial resistance profile of isolates causing clinical mastitis in dairy animals

Mastitis is the most frequent and costly disease of lactating animals and is associated with a significant reduction in milk yield, increased cost and culling. Early and specific antibiotic based treatment reduces the severity of the disease. Over the years the extensive use of antimicrobials has led to increase antimicrobial resistance. The present study was designed to investigate the prevalence of microorganisms responsible for mastitis and their antimicrobial resistance pattern. A total of 282 milk samples were collected from different animal species (sheep, cows and goats) with clinical mastitis. Antimicrobial resistance was evaluated for Streptococcus spp. and Staphylococcus spp. In cow samples Streptococcus spp. represented the most frequently isolated genus (33.84%), while Staphylococcus spp. was the most prevalent genus in sheep and goat samples (44.4 and 73.86%, respectively). Gentamicin and chloramphenicol were found to be the most effective drugs against the tested isolates, while the highest resistance rates were observed for amoxicillin, ampicillin, tetracycline, trimethoprim-sulfamethoxazole

SINEUP non-coding RNA activity depends on specific N6-methyladenosine nucleotides

: SINEUPs are natural and synthetic antisense long non-coding RNAs (lncRNAs) selectively enhancing target mRNAs translation by increasing their association with polysomes. This activity requires two RNA domains: an embedded inverted SINEB2 element acting as effector domain, and an antisense region, the binding domain, conferring target selectivity. SINEUP technology presents several advantages to treat genetic (haploinsufficiencies) and complex diseases restoring the physiological activity of diseased genes and of compensatory pathways. To streamline these applications to the clinic, a better understanding of the mechanism of action is needed. Here we show that natural mouse SINEUP AS Uchl1 and synthetic human miniSINEUP-DJ-1 are N6-methyladenosine (m6A) modified by METTL3 enzyme. Then, we map m6A-modified sites along SINEUP sequence with Nanopore direct RNA sequencing and a reverse transcription assay. We report that m6A removal from SINEUP RNA causes the depletion of endogenous target mRNA from actively translating polysomes, without altering SINEUP enrichment in ribosomal subunit-associated fractions. These results prove that SINEUP activity requires an m6A-dependent step to enhance translation of target mRNAs, providing a new mechanism for m6A translation regulation and strengthening our knowledge of SINEUP-specific mode of action. Altogether these new findings pave the way to a more effective therapeutic application of this well-defined class of lncRNAs

Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature

Background: The aim of this paper is to discuss the impact of COVID-19 on patients with urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney cancer, penile and testicular cancer) and to review the available recommendations reported in the literature. Methods: A review was performed, through the PubMed database, regarding available recommendations reported in the literature, to identify studies examining the impact of COVID-19 on treatment and clinical outcomes (including upstaging, recurrence, and mortality) for uro-oncological patients. Results: The COVID-19 pandemic dramatically changed the urological guidelines and patients’ access to screening programs and follow-up visits. Great efforts were undertaken to guarantee treatments to high-risk patients although follow up was not always possible due to recurrent surges, and patients with lower risk cancers had to wait for therapies. Conclusions: Physically and mentally, uro-oncological patients paid a heavy price during the COVID-19 pandemic. Long term data on the “costs” of clinical decisions made during the COVID-19 pandemic are still to be revealed and analyzed